2,838 Shares in Transcat, Inc. (NASDAQ:TRNS) Bought by Centiva Capital LP

Centiva Capital LP purchased a new stake in shares of Transcat, Inc. (NASDAQ:TRNSFree Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,838 shares of the scientific and technical instruments company’s stock, valued at approximately $343,000.

Several other institutional investors have also bought and sold shares of the business. Conestoga Capital Advisors LLC increased its holdings in shares of Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after buying an additional 137,830 shares during the last quarter. Calamos Advisors LLC grew its position in Transcat by 76.0% in the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock worth $1,848,000 after acquiring an additional 6,667 shares in the last quarter. Millrace Asset Group Inc. bought a new stake in Transcat during the third quarter worth approximately $655,000. Champlain Investment Partners LLC raised its position in Transcat by 22.1% during the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock valued at $49,455,000 after purchasing an additional 74,169 shares during the period. Finally, First Horizon Advisors Inc. lifted its stake in shares of Transcat by 26.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after purchasing an additional 125 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. StockNews.com downgraded Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. Northland Securities lowered their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday, October 30th. HC Wainwright reiterated a “buy” rating and set a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum decreased their price objective on shares of Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research note on Wednesday, October 30th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $130.00 target price (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Transcat currently has a consensus rating of “Hold” and an average target price of $127.25.

Get Our Latest Stock Report on Transcat

Transcat Stock Up 1.4 %

TRNS opened at $103.44 on Tuesday. The stock’s fifty day moving average is $111.96 and its two-hundred day moving average is $119.98. The company has a market capitalization of $951.65 million, a P/E ratio of 52.24 and a beta of 0.70. Transcat, Inc. has a 52 week low of $94.29 and a 52 week high of $147.12.

Transcat (NASDAQ:TRNSGet Free Report) last announced its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The firm had revenue of $67.83 million for the quarter, compared to analysts’ expectations of $70.30 million. During the same quarter in the prior year, the business posted $0.41 EPS. The business’s quarterly revenue was up 8.0% on a year-over-year basis. Equities analysts anticipate that Transcat, Inc. will post 1.76 earnings per share for the current year.

Transcat Profile

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNSFree Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.